Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons.
Study Design
- अध्ययन प्रकार
- In Vitro
- हस्तक्षेप
- Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons. 20-50 mg/kg (sedative effect in mice); 35 mg/kg (EEG/EMG in rats)
- तुलनित्र
- Placebo
- प्रभाव की दिशा
- Positive
- पूर्वाग्रह का जोखिम
- Unclear
Abstract
Corni fructus, the fruit of Cornus officinalis Sieb. et Zucc., has been used as a tonic for the kidney in China for thousands of years. Loganin is one of the major constituents derived from Corni fructus. In this study, we revealed the sedative and hypnotic activity of loganin and investigated its mechanisms for the first time. Pentobarbital-induced sleep test and insomnia mice models [induced by caffeine and p-chlorophenylalanine (PCPA)] were used for the assessment of sedative and hypnotic effects of loganin. It was found that loganin (20-50 mg/kg) exerted sedative effect in normal mice. Loganin exhibited hypnotic effect by increasing sleep onset and sleep duration in pentobarbital-treated mice, recovering PCPA-induced insomnia and exerting synergistic hypnosis effect with 5-HTP. In addition, electroencephalograph (EEG) and electromyography (EMG) recordings of rats showed that loganin (35 mg/kg) prolonged the ratio of non-rapid eye movement (NREM) sleep and shortened wakefulness significantly, further immunohistochemistry showed that loganin (35 mg/kg) increased c-Fos expression in GABAergic neurons of rats in the ventrolateral preoptic nucleus (VLPO). The levels of norepinephrine (NE), dopamine (DA), serotonin (5-HT) and its metabolite were measured in the hippocampus, prefrontal cortex and striatum of mice, 1 h after loganin (35 mg/kg) treatment. 5-HT, 5-HIAA/5-HT, DA, and DOPAC were decreased significantly in the prefrontal cortex. In conclusion, these results indicated that loganin produced beneficial sedative and hypnotic activity, which might be mainly mediated by modification of the serotonergic system and GABAergic neurons.
Full Text
Figures
FIGURE 1
Experimental design for testing loganin's sedative and hypnotic effects in mice models, including pentobarbital-induced sleep and insomnia paradigms.
diagram
FIGURE 2
Pentobarbital-induced sleep test results demonstrate that loganin administration significantly altered sleep onset latency and total sleep duration in mice.
chart
FIGURE 3
Dose-response analysis of loganin's hypnotic effects in the pentobarbital sleep model reveals concentration-dependent changes in sleep parameters.
chart
FIGURE 4
Loganin's effects on serotonergic system markers, including 5-HT levels and receptor expression in the brain, are quantified in treated versus control mice.
chart
FIGURE 5
GABAergic neuron activity measurements show that loganin modulates GABA receptor signaling, contributing to its observed sedative properties.
chart
FIGURE 6
Immunohistochemical or western blot analysis of c-Fos expression in sleep-promoting brain regions following loganin treatment indicates enhanced neuronal activation.
chart
FIGURE 7
Neurotransmitter level quantification in key brain regions demonstrates that loganin treatment alters the balance of serotonin and GABA pathways associated with sleep regulation.
chart
FIGURE 8
Behavioral analysis in insomnia mouse models shows that loganin reverses sleep disturbances induced by p-chlorophenylalanine, suggesting serotonergic involvement.
chart
FIGURE 9
Proposed mechanism of action diagram illustrates how loganin from Corni fructus exerts sedative and hypnotic effects through dual modulation of the serotonergic system and GABAergic neurons.
diagramTables
Table 1
| Groups | Dosage (mg/kg, i.g.) | No. of falling asleep/total | Sleep onset (%) |
|---|---|---|---|
| Vehicle | – | 1/25 | 4.0 |
| Estazolam | 0.15 | 25/25 | 100.0∗ |
| Loganin | 5 | 9/25 | 36.0∗ |
| 20 | 15/25 | 60.0∗ | |
| 50 | 15/25 | 60.0∗ |
Table 2
| Groups | Dosage (mg/kg) | No. of falling asleep/total | Sleep onset (%) |
|---|---|---|---|
| Vehicle | – | 0/12 | 0.0 |
| 5-HTP | 2.5 (i.p.) | 2/12 | 16.7∗ |
| Loganin | 5 (i.g.) | 2/12 | 16.7∗ |
| 5-HTP + Loganin | 2.5 (i.p.) +5 (i.g.) | 12/12 | 91.67∗∗ |
Table 3
| Group | NE (ng/g) | 5-HT (ng/g) | 5-HIAA (ng/g) | DA (ng/g) | DOPAC (ng/g) | 5-HIAA/5-HT | DOPAC/DA | |
|---|---|---|---|---|---|---|---|---|
| Control | 673.5 ± 119.1 | 1115 ± 151.4 | 337.5 ± 49.21 | 1031 ± 698.4 | 417.3 ± 145.4 | 0.29 ± 0.02 | 0.58 ± 0.18 | |
| Loganin | 469.5 ± 72.33 | 687.7 ± 91.16∗ | 241.3 ± 40.44 | 223.8 ± 56.61∗∗ | 124.7 ± 8.557∗∗ | 0.35 ± 0.05∗ | 0.63 ± 0.071 | |
| Control | 263 ± 64.29 | 466.8 ± 99.63 | 322.1 ± 73.21 | 16052 ± 3693 | 1088 ± 190.4 | 0.78 ± 0.14 | 0.09 ± 0.005 | |
| Loganin | 265.6 ± 26.61 | 723 ± 80.8 | 605.2 ± 92.07∗ | 15287 ± 1645 | 1284 ± 125.5 | 0.80 ± 0.07 | 0.09 ± 0.003 | |
| Control | 478.4 ± 78.22 | 445.6 ± 61.47 | 346.8 ± 84.66 | 66.42 ± 16.19 | ND | 0.60 ± 0.10 | ND | |
| Loganin | 515.9 ± 68.09 | 499.3 ± 62.03 | 382.7 ± 98.16 | 75.44 ± 29.22 | ND | 0.59 ± 0.11 | ND |
References
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
Used In Evidence Reviews
Similar Papers
Alternative medicine review : a journal of clinical therapeutic · 1998
5-Hydroxytryptophan: a clinically-effective serotonin precursor.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2010
Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
Pharmaceutical biology · 2019
GABA and l-theanine mixture decreases sleep latency and improves NREM sleep.
Phytotherapy research : PTR · 2018
GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence.
Medical science monitor : international medical journal of experimental and clinical research · 2009
Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.
Nutrients · 2021